Latest News about PFE
Recent news which mentions PFE
‘I decided I’d jump the gun’: What to consider before getting a booster shot if you’re not eligible yet
Today 0:49 EDT
From MarketWatch
Is AbbVie a Bad News Buy?
September 19, 2021
From Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Could Pfizer and Merck Be Big Winners With COVID Pills?
September 19, 2021
From Motley Fool
Here's Why Moderna's Stock Could Crash Before the End of 2021
September 19, 2021
From Motley Fool
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
September 19, 2021
From Motley Fool
Could This News Spark a Turnaround for Ocugen?
September 19, 2021
From Motley Fool
Barron's Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More
September 18, 2021
From Benzinga
AbbVie's Pain Is Sanofi's and Regeneron's Gain
September 18, 2021
From Motley Fool
FDA Panel Votes Against Approval Of Pfizer/BioNTech's COVID-19 Booster Shot For General Public
September 17, 2021
From Benzinga
FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster
September 17, 2021
From MarketWatch
British Study To Test Mixed COVID-19 Vaccine Regime In Kids: Reuters
September 17, 2021
From Benzinga
DNA Stock Cooks Up 10% Gains on Ginkgo Biowork’s First Trading Day
September 17, 2021
From InvestorPlace
7 Spinoff Stocks to Buy That Are Set to Outperform Their Parents
September 17, 2021
From InvestorPlace
Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising
September 17, 2021
From Motley Fool
WHO warns lack of COVID-19 vaccine supply in Africa could make it breeding ground for new variants and ‘send the whole world back to square one’
September 17, 2021
From MarketWatch
FDA Reveals COVID-19 Booster Advisory Committee Question
September 17, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Is Moderna Winning on Vaccine Efficacy?
September 17, 2021
From Motley Fool
3 Low-Risk Stocks for Conservative Investors
September 17, 2021
From Motley Fool
Investors are in an historically rotten mood. Their three biggest fears are overblown, strategist says.
September 17, 2021
From MarketWatch
U.S. stock futures struggle as options expiries loom and S&P 500 fights to hold on to a weekly gain
September 17, 2021
From MarketWatch
Why Moderna and BioNTech Topped the Market Today
September 16, 2021
From Motley Fool
With the European Union Buying Doses, Novavax Has Plenty of Upside Left
September 16, 2021
From InvestorPlace
Moderna Analysts Debate Need For Biopharma's COVID-19 Booster Shot
September 16, 2021
From Benzinga
From Benzinga
8 Health Care Stocks With Unusual Options Alerts In Today's Session
September 16, 2021
From Benzinga
U.S. passes grim milestone as 1 in 500 have now died of COVID, and debate about need for boosters heats up
September 16, 2021
From MarketWatch
2 Pharma Stocks You Can Buy and Hold for the Next Decade
September 16, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.